Alimera Sciences Stock Price To Sales
| ALIMDelisted Stock | USD 5.54 0.01 0.18% |
Alimera Sciences fundamentals help investors to digest information that contributes to Alimera Sciences' financial success or failures. It also enables traders to predict the movement of Alimera Stock. The fundamental analysis module provides a way to measure Alimera Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alimera Sciences stock.
Alimera |
Alimera Sciences Company Price To Sales Analysis
Alimera Sciences' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Alimera Sciences Price To Sales | 3.02 X |
Most of Alimera Sciences' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alimera Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, Alimera Sciences has a Price To Sales of 3.0225 times. This is 85.88% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 73.53% higher than that of the company.
Alimera Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alimera Sciences' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alimera Sciences could also be used in its relative valuation, which is a method of valuing Alimera Sciences by comparing valuation metrics of similar companies.Alimera Sciences is currently under evaluation in price to sales category among its peers.
Alimera Fundamentals
| Return On Equity | -0.35 | |||
| Return On Asset | 0.0098 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 360.44 M | |||
| Shares Outstanding | 54.38 M | |||
| Shares Owned By Insiders | 5.34 % | |||
| Shares Owned By Institutions | 86.54 % | |||
| Number Of Shares Shorted | 578.49 K | |||
| Price To Earning | 1.65 X | |||
| Price To Book | 7.77 X | |||
| Price To Sales | 3.02 X | |||
| Revenue | 80.75 M | |||
| Gross Profit | 52 M | |||
| EBITDA | 7.28 M | |||
| Net Income | (20.13 M) | |||
| Cash And Equivalents | 7.86 M | |||
| Cash Per Share | 1.12 X | |||
| Total Debt | 67.4 M | |||
| Current Ratio | 1.30 X | |||
| Book Value Per Share | 0.74 X | |||
| Cash Flow From Operations | (14.26 M) | |||
| Short Ratio | 1.93 X | |||
| Earnings Per Share | 1.05 X | |||
| Target Price | 5.67 | |||
| Number Of Employees | 154 | |||
| Beta | 1.25 | |||
| Market Capitalization | 301.29 M | |||
| Total Asset | 153.52 M | |||
| Retained Earnings | (418.49 M) | |||
| Working Capital | 30.51 M | |||
| Current Asset | 51.6 M | |||
| Current Liabilities | 7.85 M | |||
| Net Asset | 153.52 M |
About Alimera Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alimera Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alimera Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alimera Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |